Literature DB >> 11213315

Pathogenesis of gastroesophageal reflux and Barrett esophagus.

N S Buttar1, G W Falk.   

Abstract

Barrett esophagus is a metaplastic condition that affects the lower esophagus and is a complication of gastroesophageal reflux disease (GERD). Under normal circumstances, the reflux of gastric contents into the esophagus is prevented by a complex barrier at the esophagogastric junction. Dysfunction of the lower esophageal sphincter and the presence of a hiatal hernia lead to failure of this barrier. Esophageal mucosal damage results from the chronic exposure of the esophageal mucosa to gastroduodenal contents and the lack of an effective mucosal defense. This article is an overview of the dysfunction of the esophagogastric junction that leads to GERD. The role of the contents of the reflux and that of Helicobacter pylori infection in the pathogenesis of Barrett esophagus are also summarized.

Entities:  

Mesh:

Year:  2001        PMID: 11213315     DOI: 10.1016/S0025-6196(11)63134-0

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  10 in total

1.  Laparoscopic transhiatal approach for resection of an adenocarcinoma in long-segment Barrett's esophagus.

Authors:  Atsushi Shiozaki; Hitoshi Fujiwara; Hirotaka Konishi; Osamu Kinoshita; Toshiyuki Kosuga; Ryo Morimura; Yasutoshi Murayama; Shuhei Komatsu; Yoshiaki Kuriu; Hisashi Ikoma; Masayoshi Nakanishi; Daisuke Ichikawa; Kazuma Okamoto; Chouhei Sakakura; Eigo Otsuji
Journal:  World J Gastroenterol       Date:  2015-08-07       Impact factor: 5.742

2.  Prevalence of Barrett's esophagus remains low in the Korean population: nationwide cross-sectional prospective multicenter study.

Authors:  In Seok Lee; Suck Chei Choi; Ki Nam Shim; Sam Ryong Jee; Kyu Chan Huh; Jun Haeng Lee; Kwang Jae Lee; Hyung Seok Park; Yong Chan Lee; Hoon Yong Jung; Hyo Jin Park
Journal:  Dig Dis Sci       Date:  2009-10-03       Impact factor: 3.199

3.  Rabeprazole and esomeprazole in mild-to-moderate erosive gastroesophageal reflux disease: A comparative study of efficacy and safety.

Authors:  Rituparna Maiti; Jyothirmai Jaida; P L John Israel; Narendar Koyagura; Sruthi Mukkisa; Anuradha Palani
Journal:  J Pharmacol Pharmacother       Date:  2011-07

4.  Impact of Chronic Statins Use on the Development of Esophagitis in Patients with Gastroesophageal Reflux Disease.

Authors:  Tawfik Khoury; Amir Mari; Hana Amara; Mohamed Jabaren; Abdulla Watad; Wiliam Nseir; Wisam Sbeit; Mahmud Mahamid
Journal:  Can J Gastroenterol Hepatol       Date:  2019-02-03

Review 5.  Review article: oesophageal complications and consequences of persistent gastro-oesophageal reflux disease.

Authors:  J Pisegna; G Holtmann; C W Howden; P H Katelaris; P Sharma; S Spechler; G Triadafilopoulos; G Tytgat
Journal:  Aliment Pharmacol Ther       Date:  2004-12       Impact factor: 8.171

6.  Current trends in the management of gastroesophageal reflux disease: a review.

Authors:  Sylvester Chuks Nwokediuko
Journal:  ISRN Gastroenterol       Date:  2012-07-11

7.  CagA-positive Helicobacter pylori infection is not associated with decreased risk of Barrett's esophagus in a population with high H. pylori infection rate.

Authors:  Angel Ferrández; Rafael Benito; Juan Arenas; María Asunción García-González; Federico Sopeña; Javier Alcedo; Javier Ortego; Ricardo Sainz; Angel Lanas
Journal:  BMC Gastroenterol       Date:  2006-02-16       Impact factor: 3.067

8.  Is Atrial Fibrillation a Risk Factor for Gastroesophageal Reflux Disease Occurrence?

Authors:  Jae Jin Hwang; Dong Ho Lee; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Nayoung Kim
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

9.  GASTROESOPHAGEAL REFLUX DISEASE AND ETIOLOGICAL CORRELATES AMONG NIGERIAN ADULTS AT OGBOMOSO.

Authors:  A C Jemilohun; B O Oyelade; J O Fadare; I O Amole
Journal:  Ann Ib Postgrad Med       Date:  2018-06

10.  Helicobacter pylori infection is associated with reduced risk of Barrett's esophagus: a meta-analysis and systematic review.

Authors:  Yan-Lin Du; Ru-Qiao Duan; Li-Ping Duan
Journal:  BMC Gastroenterol       Date:  2021-12-07       Impact factor: 3.067

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.